US Stock MarketDetailed Quotes

APLS Apellis Pharmaceuticals

Watchlist
  • 25.150
  • -0.850-3.27%
Close Feb 28 16:00 ET
  • 26.000
  • +0.850+3.38%
Post 20:01 ET
3.16BMarket Cap-15.72P/E (TTM)

Apellis Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
97.02%781.37M
45.19%212.53M
78.29%196.83M
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
Operating revenue
97.02%781.37M
45.19%212.53M
78.29%196.83M
110.26%199.69M
284.26%172.33M
425.83%396.59M
545.89%146.38M
400.54%110.4M
481.85%94.97M
211.84%44.85M
Cost of revenue
101.20%117.72M
105.18%40.86M
49.74%33.56M
175.69%23.1M
158.79%20.21M
938.15%58.51M
580.75%19.91M
1,522.74%22.41M
10,118.29%8.38M
526.22%7.81M
Gross profit
96.30%663.64M
35.75%171.67M
85.56%163.27M
103.93%176.59M
310.71%152.12M
384.45%338.08M
540.72%126.47M
325.58%87.99M
433.19%86.59M
181.99%37.04M
Operating expense
-3.11%828.62M
-6.23%197.84M
-6.45%210.55M
-0.48%206.03M
0.98%214.21M
28.72%855.2M
14.80%210.98M
29.64%225.07M
25.58%207.03M
49.24%212.12M
Selling and administrative expenses
0.05%501.05M
-14.27%121.48M
-16.25%121.98M
15.00%128.08M
26.85%129.51M
80.69%500.82M
67.96%141.7M
85.76%145.65M
76.21%111.37M
99.45%102.09M
Research and development costs
-7.57%327.57M
10.21%76.35M
11.52%88.57M
-18.51%77.95M
-23.02%84.7M
-8.48%354.39M
-30.32%69.28M
-16.58%79.42M
-5.90%95.66M
20.98%110.03M
Operating profit
68.10%-164.98M
69.04%-26.16M
65.51%-47.28M
75.55%-29.44M
64.54%-62.09M
13.03%-517.12M
48.48%-84.52M
10.37%-137.08M
18.96%-120.44M
-35.73%-175.08M
Net non-operating interest income expense
-219.36%-27.62M
-185.14%-8.14M
-315.47%-9.64M
-361.17%-6.18M
-71.54%-3.66M
63.53%-8.65M
9.77%-2.85M
54.44%-2.32M
80.92%-1.34M
74.69%-2.14M
Non-operating interest income
-38.98%12.77M
-25.33%3.4M
-42.09%2.89M
-46.95%3.18M
-38.75%3.3M
134.83%20.93M
-0.59%4.55M
77.61%4.99M
319.13%6M
5,403.06%5.39M
Non-operating interest expense
36.54%40.39M
55.82%11.53M
71.44%12.53M
27.49%9.36M
-7.46%6.97M
-9.33%29.58M
-4.34%7.4M
-7.50%7.31M
-13.10%7.34M
-11.82%7.53M
Other net income (expense)
-466.57%-4.12M
-905.94%-1.77M
111.61%70K
-2,955.56%-1.93M
-80.14%-499K
97.81%-727K
189.02%219K
98.16%-603K
-142.28%-63K
4.15%-277K
Special income (charges)
---1.95M
--0
--0
---1.95M
----
--0
--0
--0
--0
----
-Less:Other special charges
--1.95M
--0
----
--1.95M
----
----
----
----
----
----
Other non- operating income (expenses)
-198.49%-2.17M
-905.94%-1.77M
111.61%70K
138.10%24K
-80.14%-499K
-152.43%-727K
189.02%219K
-709.09%-603K
-142.28%-63K
4.15%-277K
Income before tax
62.64%-196.72M
58.62%-36.07M
59.39%-56.85M
69.19%-37.54M
62.67%-66.25M
19.19%-526.5M
47.96%-87.15M
26.63%-140M
21.64%-121.84M
-28.88%-177.5M
Income tax
-45.50%1.16M
-79.90%286K
154.08%592K
-41.24%114K
-39.72%170K
218.68%2.13M
196.74%1.42M
-47.76%233K
-60.08%194K
-76.66%282K
Net income
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
Net income continuous Operations
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
Minority interest income
Net income attributable to the parent company
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.57%-197.88M
58.96%-36.35M
59.04%-57.45M
69.14%-37.66M
62.64%-66.42M
18.94%-528.63M
46.64%-88.58M
26.68%-140.24M
21.76%-122.04M
-27.96%-177.78M
Basic earnings per share
64.04%-1.6
60.27%-0.29
60.68%-0.46
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
Diluted earnings per share
64.04%-1.6
60.27%-0.29
60.68%-0.46
70.59%-0.3
65.38%-0.54
27.64%-4.45
51.33%-0.73
33.14%-1.17
30.14%-1.02
-9.86%-1.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 97.02%781.37M45.19%212.53M78.29%196.83M110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M
Operating revenue 97.02%781.37M45.19%212.53M78.29%196.83M110.26%199.69M284.26%172.33M425.83%396.59M545.89%146.38M400.54%110.4M481.85%94.97M211.84%44.85M
Cost of revenue 101.20%117.72M105.18%40.86M49.74%33.56M175.69%23.1M158.79%20.21M938.15%58.51M580.75%19.91M1,522.74%22.41M10,118.29%8.38M526.22%7.81M
Gross profit 96.30%663.64M35.75%171.67M85.56%163.27M103.93%176.59M310.71%152.12M384.45%338.08M540.72%126.47M325.58%87.99M433.19%86.59M181.99%37.04M
Operating expense -3.11%828.62M-6.23%197.84M-6.45%210.55M-0.48%206.03M0.98%214.21M28.72%855.2M14.80%210.98M29.64%225.07M25.58%207.03M49.24%212.12M
Selling and administrative expenses 0.05%501.05M-14.27%121.48M-16.25%121.98M15.00%128.08M26.85%129.51M80.69%500.82M67.96%141.7M85.76%145.65M76.21%111.37M99.45%102.09M
Research and development costs -7.57%327.57M10.21%76.35M11.52%88.57M-18.51%77.95M-23.02%84.7M-8.48%354.39M-30.32%69.28M-16.58%79.42M-5.90%95.66M20.98%110.03M
Operating profit 68.10%-164.98M69.04%-26.16M65.51%-47.28M75.55%-29.44M64.54%-62.09M13.03%-517.12M48.48%-84.52M10.37%-137.08M18.96%-120.44M-35.73%-175.08M
Net non-operating interest income expense -219.36%-27.62M-185.14%-8.14M-315.47%-9.64M-361.17%-6.18M-71.54%-3.66M63.53%-8.65M9.77%-2.85M54.44%-2.32M80.92%-1.34M74.69%-2.14M
Non-operating interest income -38.98%12.77M-25.33%3.4M-42.09%2.89M-46.95%3.18M-38.75%3.3M134.83%20.93M-0.59%4.55M77.61%4.99M319.13%6M5,403.06%5.39M
Non-operating interest expense 36.54%40.39M55.82%11.53M71.44%12.53M27.49%9.36M-7.46%6.97M-9.33%29.58M-4.34%7.4M-7.50%7.31M-13.10%7.34M-11.82%7.53M
Other net income (expense) -466.57%-4.12M-905.94%-1.77M111.61%70K-2,955.56%-1.93M-80.14%-499K97.81%-727K189.02%219K98.16%-603K-142.28%-63K4.15%-277K
Special income (charges) ---1.95M--0--0---1.95M------0--0--0--0----
-Less:Other special charges --1.95M--0------1.95M------------------------
Other non- operating income (expenses) -198.49%-2.17M-905.94%-1.77M111.61%70K138.10%24K-80.14%-499K-152.43%-727K189.02%219K-709.09%-603K-142.28%-63K4.15%-277K
Income before tax 62.64%-196.72M58.62%-36.07M59.39%-56.85M69.19%-37.54M62.67%-66.25M19.19%-526.5M47.96%-87.15M26.63%-140M21.64%-121.84M-28.88%-177.5M
Income tax -45.50%1.16M-79.90%286K154.08%592K-41.24%114K-39.72%170K218.68%2.13M196.74%1.42M-47.76%233K-60.08%194K-76.66%282K
Net income 62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M
Net income continuous Operations 62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M
Minority interest income
Net income attributable to the parent company 62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.57%-197.88M58.96%-36.35M59.04%-57.45M69.14%-37.66M62.64%-66.42M18.94%-528.63M46.64%-88.58M26.68%-140.24M21.76%-122.04M-27.96%-177.78M
Basic earnings per share 64.04%-1.660.27%-0.2960.68%-0.4670.59%-0.365.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.56
Diluted earnings per share 64.04%-1.660.27%-0.2960.68%-0.4670.59%-0.365.38%-0.5427.64%-4.4551.33%-0.7333.14%-1.1730.14%-1.02-9.86%-1.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
TeraWulf
WULF
+16.07%
Bitdeer Technologies
BTDR
+13.04%
Riot Platforms
RIOT
+7.16%
Bitfarms
BITF
+6.42%
CleanSpark
CLSK
+6.39%

Unlock the Full List

Investment Theme Gene Editing
Gene Editing
Intraday+0.83%